849470-59-3 Usage
Description
4-(4-Fluorophenyl)-5-hydroxymethyl-6-isopropyl-2-methylsulfonylpyrimidine is a chemical compound characterized by its unique molecular structure, which features a pyrimidine core with various substituents. 4-(4-Fluorophenyl)-5-hydroxymethyl-6-isopropyl-2-methylsulfonylpyrimidine is known for its potential applications in organic synthesis, making it a valuable component in the development of new chemical entities.
Uses
Used in Organic Synthesis:
4-(4-Fluorophenyl)-5-hydroxymethyl-6-isopropyl-2-methylsulfonylpyrimidine is used as a synthetic intermediate for the development of various organic compounds. Its unique structure allows it to be a versatile building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(4-Fluorophenyl)-5-hydroxymethyl-6-isopropyl-2-methylsulfonylpyrimidine is used as a key component in the synthesis of drug candidates. Its presence in the molecular structure can contribute to the desired pharmacological properties, such as potency, selectivity, and bioavailability, making it an essential part of the drug discovery process.
Used in Agrochemical Industry:
4-(4-Fluorophenyl)-5-hydroxymethyl-6-isopropyl-2-methylsulfonylpyrimidine also finds application in the agrochemical industry, where it is utilized in the synthesis of novel pesticides and herbicides. Its incorporation into these compounds can lead to improved efficacy and selectivity, ultimately contributing to more effective crop protection solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 849470-59-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,4,7 and 0 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 849470-59:
(8*8)+(7*4)+(6*9)+(5*4)+(4*7)+(3*0)+(2*5)+(1*9)=213
213 % 10 = 3
So 849470-59-3 is a valid CAS Registry Number.
849470-59-3Relevant articles and documents
Development of a scaleable process for the synthesis of a next-generation statin
Hobson, Lindsay A.,Akiti, Otute,Deshmukh, Subodh S.,Harper, Shannon,Katipally, Kishta,Lai, Chiajen J.,Livingston, Robert C.,Lo, Ehrlic,Miller, Michael M.,Ramakrishnan, Srividya,Shen, Lifen,Spink, Jan,Tummala, Srinivas,Wei, Chenkou,Yamamoto, Kana,Young, John,Parsons Jr., Rodney L.
scheme or table, p. 441 - 458 (2011/04/22)
This manuscript details the process research and development of a convergent and safe approach to 1 on a multikilo scale. Specific highlights of the process development efforts will be described, including the development of a dehydrogenation method for d
PYRIMIDINE AND PYRIDINE DERIVATIVES USEFUL AS HMG-COA REDUCTASE INHIBITORS AND METHOD OF PREPARATION THEREOF
-
Page/Page column 54-55, (2010/02/11)
Compounds are provided having the following structure which are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol
